Your browser doesn't support javascript.
loading
Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial.
Atmowihardjo, Leila N; Schippers, Job R; Duijvelaar, Erik; Bartelink, Imke H; Bet, Pierre M; Swart, Noortje E L; van Rein, Nienke; Purdy, Keith; Cavalla, David; McElroy, Andrew; Fritchley, Sarah; Vonk Noordegraaf, Anton; Endeman, Henrik; van Velzen, Patricia; Koopmans, Matty; Bogaard, Harm Jan; Heunks, Leo; Juffermans, Nicole; Schultz, Marcus J; Tuinman, Pieter R; Bos, Lieuwe D J; Aman, Jurjan.
Afiliação
  • Atmowihardjo LN; Intensive Care, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Schippers JR; Department of Pulmonary Medicine, Amsterdam University Medical Centers, Location VUmc, Room number 5A-074, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • Duijvelaar E; Department of Pulmonary Medicine, Amsterdam University Medical Centers, Location VUmc, Room number 5A-074, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • Bartelink IH; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, Amsterdam, The Netherlands.
  • Bet PM; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, Amsterdam, The Netherlands.
  • Swart NEL; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, Amsterdam, The Netherlands.
  • van Rein N; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Purdy K; Department of Clinical Pharmacology and Pharmacy, Leiden UMC, Albinusdreef 2, Leiden, The Netherlands.
  • Cavalla D; Exvastat, Cambridge, England.
  • McElroy A; Exvastat, Cambridge, England.
  • Fritchley S; Exvastat, Cambridge, England.
  • Vonk Noordegraaf A; Exvastat, Cambridge, England.
  • Endeman H; Department of Pulmonary Medicine, Amsterdam University Medical Centers, Location VUmc, Room number 5A-074, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • van Velzen P; Intensive Care, Erasmus University Medical Centre, Doctor Molewaterplein 40, Rotterdam, The Netherlands.
  • Koopmans M; Intensive Care, Dijklander Hospital, Location Purmerend, Waterlandlaan 250, Purmerend, The Netherlands.
  • Bogaard HJ; Intensive Care, OLVG Hospital Location Oost, Oosterpark 9, Amsterdam, The Netherlands.
  • Heunks L; Department of Pulmonary Medicine, Amsterdam University Medical Centers, Location VUmc, Room number 5A-074, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
  • Juffermans N; Intensive Care, Erasmus University Medical Centre, Doctor Molewaterplein 40, Rotterdam, The Netherlands.
  • Schultz MJ; Intensive Care, OLVG Hospital Location Oost, Oosterpark 9, Amsterdam, The Netherlands.
  • Tuinman PR; Laboratory of Translational Intensive Care, Erasmus University, Rotterdam, The Netherlands.
  • Bos LDJ; Intensive Care, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Aman J; Mahidol Oxford Tropical Medicine Research Unit (MORU), Mahidol University, Bangkok, Thailand.
Crit Care ; 27(1): 226, 2023 06 08.
Article em En | MEDLINE | ID: mdl-37291677

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Edema Pulmonar / Síndrome do Desconforto Respiratório / COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Crit Care Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Edema Pulmonar / Síndrome do Desconforto Respiratório / COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Crit Care Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda